Skip to main content
. 2023 Dec 21;10:1238562. doi: 10.3389/fmed.2023.1238562

Table 2.

Summary of outcome measures by treatment group using linear mixed model.

Outcomes Baseline 5-week post baseline 9-week post baseline 12-week post baseline
Mean (SD) Mean (SD) MD (95% CI) Mean (SD) MD (95% CI) Mean (SD) MD (95% CI)
Between group comparison
EQ-5D
Intervention 5.59 (1.04) 5.67 (1.06) −0.03 (−0.31 to 0.24) 5.61 (0.96) −0.12 (−0.47 to 0.23) 5.57 (0.90) 0.003 (−0.38 to 0.38)
Control 5.55 (1.04) 5.66 (0.86) 5.68 (0.81) 5.53 (1.10)
EQ-5D VAS
Intervention 85.9 (9.95) 84.7 (11.3) −1.90 (−6.14 to 2.35) 86.3 (9.61) 0.47 (−3.93 to 4.87) 86.3 (9.42) −0.54 (−4.96 to 3.89)
Control 85.3 (12.8) 85.9 (9.54) 84.9 (14.6) 85.9 (10.5)
CESAM (Frailty)
Intervention 1.46 (1.85) 1.65 (2.01) −0.11 (−0.67 to 0.45) 1.02 (1.60) −0.52 (−1.09 to 0.05) 1.15 (1.53) −0.24 (−0.81 to 0.33)
Control 1.88 (1.50) 2.18 (2.09) 1.95 (1.80) 1.80 (1.73)
Pre-test WEMWBS
Intervention 57.7 (8.42) 57.7 (8.20) 0.05 (−1.60 to 1.71) 58.1 (8.02) 0.17 (−1.97 to 2.31) 58.6 (8.09) −0.11 (−2.53 to 2.30)
Control 57.9 (6.78) 57.8 (6.35) 58.0 (6.43) 58.7 (7.63)
Within intervention group only (pairwise) comparison
CESAM (Frailty) 1.46 (1.85) 1.65 (2.01) 0.19 (−0.20 to 0.59) 1.02 (1.60) −0.44 (−0.85 to −0.04) 1.15 (1.53) −0.32 (−0.72 to 0.09)
Post-test WEMWBS 55.7 (7.18) 56.7 (8.50) 0.82 (−0.41 to 2.05) 57.6 (8.36) 1.65 (0.09 to 3.22) 58.5 (8.22) 2.42 (0.69 to 4.16)

VAS, Visual Analog Scale; WEMWBS, Warwick-Edinburgh Wellbeing Scale; SD, standard deviation; MD, mean difference; CI, confidence interval. Between group MD was calculated by the linear mixed model and each model was adjusted for age, sex, ethnicity, education, marital status, employment status, presence of chronic illness, number of workshops done, and baseline physical activity.